FERNANDO ATAULFO
GONZÁLEZ FERNÁNDEZ
Profesor asociado de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (35)
2024
-
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy
Blood, Vol. 143, Núm. 18, pp. 1807-1815
-
Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut
Annals of Hematology, Vol. 103, Núm. 3, pp. 725-727
2023
-
Artificial intelligence to assist specialists in the detection of haematological diseases
Heliyon, Vol. 9, Núm. 5
-
Mutations in the RACGAP1 gene cause autosomal recessive congenital dyserythropoietic anemia type III
Haematologica
-
Two new mutations in the GLRX5 gene cause sideroblastic anemia
Blood Cells, Molecules, and Diseases
2022
-
Does size matter? Two new deletions in the HBB gene cause β0-thalassemia
Annals of Hematology, Vol. 101, Núm. 7, pp. 1465-1471
-
Gastrointestinal: Pancytopenia and polyclonal hypergammaglobulinemia in a 52-year-old immunocompromised woman
Journal of Gastroenterology and Hepatology (Australia), Vol. 37, Núm. 11, pp. 2029
-
Pincered red cells in hereditary spherocytosis
Annals of Hematology
-
β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
Frontiers in Medicine, Vol. 9
2021
-
Hb Maruchi [α165 (E14) Ala>Pro; HBA1: c.196G>C]: A new thalassemia hemoglobinopathy related to the alpha1 globin gene
Clinical Biochemistry, Vol. 92, pp. 77-81
-
Interference of Hemoglobin (Hb) Hope on Measurement of HbA1c Using an HPLC Method
Journal of Diabetes Science and Technology
-
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab
European Journal of Haematology, Vol. 106, Núm. 3, pp. 389-397
-
Sickle cell disease associated with thalassemia; description of a rare mutation
Clinical Biochemistry, Vol. 94, pp. 80-82
-
Why is the novel Hb Miguel Servet visualised by CE-HPLC newborn and not by the CE-HPLC β-thalassaemia programme?
Journal of Clinical Pathology, Vol. 74, Núm. 3, pp. 198-201
2020
2019
-
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: The 302 study
Blood, Vol. 133, Núm. 6, pp. 540-549
2018
-
Clinical and genetic features of congenital dyserythropoietic anemia (CDA)
European Journal of Haematology, Vol. 101, Núm. 3, pp. 368-378
2017
-
Hb Moncloa: A new variant of haemoglobin that interferes in the quantification of Hb A1c
Clinical Biochemistry, Vol. 50, Núm. 9, pp. 521-524
-
Phenotype of mutations in the promoter region of the β-globin gene
Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 874-878
2016
-
HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran Vía [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364-366dupGTG]: Description of five new hemoglobinopathies
Clinical Chemistry and Laboratory Medicine, Vol. 54, Núm. 4, pp. 553-560